SUMMARY
The use of sterile plastic sleeves to protect pulmonary artery catheters (PAC) may decrease infection risk. The catheter may require manipulation but contamination of the sleeve risks inoculating organisms into the patients. We sought to determine whether the sleeve remains sterile and for how long.
We conducted a prospective observational study to culture the components of the PAC in a critically ill population. Upon removal we cultured 1) the PAC tip, 2) the PAC introducer exit site, 3) the PAC introducer hub and 4) a sterile irrigant solution which ran down the inside of the protective sleeve. Demographic, catheter and disease variables were also collected.
There were 102 PAC episodes amounting to 3952 catheter hours with a mean duration of catheterisation of 39. 1 (24.2) hours. There were 17 positive culture results, of which six were positive sleeve fluid cultures. In three of these patients the exit site was culture positive, and the same organism was isolated as within the sleeve. No patient had a positive blood culture. There was no difference between those with and without a positive sleeve culture in terms of demographic or disease variables.
The protective sleeve of the pulmonary artery catheter does not remain sterile and should not be considered as a sterile barrier. We believe that manipulating the PAC within the sleeve carries the risk of inoculating the patient with pathogenic organisms. The duration of sterility remains to be determined. January 2008. All PACs were inserted either in operating theatres or in our multidisciplinary intensive care unit (ICU). Prospectively collected patient data included Acute Physiology and Chronic Health Evaluation 12 (APACHE) II and Sequential Organ Failure 13 (SOFA) scores for the first 96 hours; patient age and gender, type of PAC, site of PAC insertion, date and time of insertion as well as type of surgery, medical diagnosis and antibiotic therapy at the time of PAC insertion and removal.
All PACs were inserted by a consultant anaesthetist, intensive care physician or a trainee under direct specialist supervision with strict adherence to guidelines for aseptic insertion technique (threeminute hand scrub, use of mask, sterile gown and gloves, skin preparation with chlorhexidine 2% and generous sterile draping). Under ultrasound guidance, an 8.5 F Teflon, non-antibiotic-impregnated introducer was inserted percutaneously into a central vein and was anchored with a suture. A heparinbonded PAC (Arrow ® ), either for continuous or intermittent cardiac output monitoring, was advanced through a sterile, expandible plastic sheath and through the introducer. When insertion was completed, the sterile sheath was locked into position onto the introducer hub and onto the proximal portion of the PAC, thus sealing the system entirely. Stopcocks were connected to the right atrium and the pulmonary artery lumens. The pulmonary artery port was connected to a pressure transducer and the right atrium port was connected to a 5% glucose solution. A chlorhexidine-impregnated sponge (Biopatch ® ) was applied before covering the site with a sterile polyurethane dressing (Tegaderm ® ). These patches are a standard of care in our unit and all catheters are dressed in exactly the same fashion. In all patients the dressings remained intact for the duration of the study.
For the purposes of the study, advancement of the PAC was not permitted beyond four hours after insertion, in accordance with the unit protocol. PAC insertion sites were inspected daily for any signs of infection. The decision to remove the PAC was made independently by the ICU consultant. At the time of PAC removal, the duration of catheterisation was recorded and four specimens were obtained as follows: Samples 1. PAC sleeve fluid: Following disinfection of the exterior of the PAC sleeve with topical 2% chlorhexidine, 30 ml of sterile 0.9% saline was injected into the PAC sleeve with a 20 gauge needle. The saline was gently agitated for 20 seconds to ensure contact of the injected fluid with the surface of the sleeve, then reaspirated and placed into a sterile container ("sleeve fluid"). 2. PAC tip: The PAC sleeve was then disconnected from the hub of the introducer and the PAC was removed, with the distal 5 cm cut-off with sterile scissors and forceps and placed into a sterile container. 3,4. PAC hub swab and exit site swabs: Rayon-tipped swabs were used to sample the surface of the PAC introducer hub and from the skin at the PAC exit site which were then placed directly into charcoal-containing Amies Transport media ® .
All specimens were then transported directly to the microbiology laboratory for immediate processing.
In the laboratory, up to 10 ml of the sleeve fluid was centrifuged at 3000 rpm for 15 minutes. Following centrifugation, the supernatant was discarded, leaving approximately 1 ml of fluid to re-suspend the 'pellet'. One hundred microlitres of this fluid was inoculated onto 5% horse blood agar, then incubated aerobically in 5% CO 2 at 35°C for 48 hours. Following incubation, colony counts were performed and colony forming units of bacteria/millilitre (CFU/ml) of 'sleeve fluid' were calculated, adjusting for the volume of centrifuged fluid. PAC tips were inoculated directly onto 5% horse blood agar using the Maki roll-plate technique 14 and incubated aerobically in 5% CO 2 at 35°C for 48 hours. The PAC hub and PAC exit site swabs were inoculated directly onto 5% horse blood agar and incubated aerobically at 35°C in 5% CO 2 for 48 hours. Growth of organisms was then observed and reported.
Identification of organisms to the genus and/or species level was performed according to standard laboratory methods. Culture results were interpreted by a clinical microbiologist blinded to the patient details. The decision to take blood cultures was made independently by the intensive care specialist. When indicated, 20 ml of venous blood was drawn simultaneously through the PAC and from peripheral veins with aseptic technique, and cultured in aerobic and anaerobic media (10 ml each) using commercially available platform (BacT-Alert ® , Organon-Technica).
Definitions
Catheter-related infection was defined according to the Centers for Disease Control and Prevention criteria 15 . PAC sleeve cultures were defined as "no growth" (0 CFU per ml) or "growth" (≥1 CFU per ml) 16 . Positive PAC tip growth was defined as >15 CFU per plate 14 . Rather than use the imprecise terms "colonisation" or "contamination" for external surface sampling results (i.e. exit site and PAC hub swabs) as previous authors have done 17 we reported culture of these specimens as "no growth", "scanty" growth (1+ or 2+), "moderate" growth (3+) or "abundant" growth (4+), according to routine laboratory practice.
Statistical analysis
Statistic analysis was performed using SPSS for Windows (version 15, SPSS Inc, Chicago, IL, USA, 2001) . Continuous data are presented as means ± standard deviation. Unpaired t-tests were performed to compare parametric variables. Categorical data were analysed using chi-square tests. P values of <0.05 were considered statistically significant.
RESULTS
Between April 2007 and January 2008, 102 consecutive patients were included in the study, amounting to a total of 3952 catheter-hours. Seventy patients (68.6%) were male and 32 (31.4%) female; mean age was 63 (± 16) years. The diagnostic subgroups, illness severity scores, patient demographics and catheter details are described in Table 1 . The patient cohort comprised largely postoperative cardiac surgical patients (82.4%), including transplants. Ninety-two (90.2%) patients had PACs inserted into the internal jugular vein, eight patients (7.8%) into the subclavian vein and two patients (2%) into the femoral vein. In 81 patients (79.4%) intermittent cardiac output PACs were used and in 21 (20.6%) continuous cardiac output PACs. Eighty-five PACs (83.3%) were inserted in operating theatres and 17 (16.7%) in ICU. Of the 17 inserted in ICU, five were in postoperative cardiac surgical patients and the remainder (12) were in those with a variety of medical conditions. In all cases of ICU insertion, the indication was haemodynamic instability. Mean PAC residence was 39.1 hours (± 24.4 hours). At the time of PAC removal, 10 patients (8.9%) were not on antibiotic therapy, 72 patients (70.6%) were receiving one antibiotic, 18 patients (17.6%) were receiving two antibiotics and two patients (2.9%) three antibiotics. Of the six patients with positive sleeve cultures, two were on vancomycin alone, three were on flucloxacillin alone and one was on moxifloxacin.
MICROBIOLOGY RESULTS
There were a total of 43 positive cultures observed (Table 2) , equating to an incidence density of 159 per 1000 catheter days. Of the positive cultures, three had mixed growth. The most common organisms overall were coagulase-negative staphylococci (CNS) (36/43), with various gram-negative isolates (7/43) and diptheroids (2/43). Thirty introducer exit site swabs, seven introducer hubs swabs and six PAC sleeve fluids were culture-positive, in a total of 35 patients (34.3% PAC culture positive). Blood cultures were taken in 11 patients who were admitted with medical conditions. These blood cultures were all negative. None of the elective surgical patients had blood cultures while the PAC was in situ. Eight patients had more than one positive site. All PAC tips were sterile. Of the six patients with culture-positive PAC sleeve fluid, two (33%) had no other positive sites, two (33%) had either culture-positive exit sites or introducer hubs and two (1.9%) had positive cultures at both other sites. In three of the four patients with positive sleeve fluid and other positive sites, the exit site was also culture-positive. In every case, the same organisms were cultured from the sleeve fluid and the other positive sites. These were CNS. Six of the positive cultures grew gram-negative bacilli (one sleeve fluid, one hub and four exit sites).
There were no significant differences between patients with negative and positive cultures in terms of age, APACHE score, day one SOFA score, duration of placement (Dwell-time), gender, catheter site or type, or the number of antibiotics at the time of removal.
DISCUSSION
Pulmonary artery catheterisation remains a widely used tool for the haemodynamic assessment of critically ill patients in operating theatres and intensive care. Infective complications are a particular threat in this population. This is not only due to serious medical comorbidities and to the nature and extent of surgery these patients may undergo. It is also due to the use of various indwelling devices and the exposure to nosocomial organisms in the context of induced or reactive immunosuppression. Therefore, safe and sterile handling of the PAC during and after its insertion is very important. As PACs tend to migrate from the position that permits measurement of the pulmonary artery occlusion pressure, regular manipulation of the catheter may become necessary. This was facilitated by the introduction of transparent sleeves in the 1990s which are designed to protect the catheter and keep it sterile 11 . To our knowledge, no study has addressed the question of how long this protective sleeve remains sterile and for how long it is safe to advance the catheter within the sleeve.
Our results are of concern. They show that in a cohort of predominantly elective cardiac surgical patients, approximately 6% of PAC sleeves are contaminated within a mean of 30.8 hours after insertion. Other authors have shown that the cumulative risk for central venous catheter-related infection increases the longer the catheter is in place 18 , but this risk seems to increase significantly only after four days of catheter placement.
Our figures of positive growth in 34.3% of 102 PACs are higher than those of previous studies 17 , although ours is the first to extensively evaluate the components of the closed ('hands-off') PAC system. Most previous studies have only cultured catheters that have been in situ for at least 48 hours 17, 19 . In our study with predominantly short-stay patients, none had a positive PAC tip culture and the positive cultures were predominantly surface swabs where bacteria would be expected to be cultured (i.e. PAC exit site and hub cultures). The proportion of exit site (29.4% vs. 23.8%) and hub (5.9% vs. 4.1%) swabs that were culture-positive was higher in our study than in a previous cohort, however 19 . In a study by Bouza et al, at least 15 colony forming units per plate were required to confirm 'colonisation' 20 . In contrast to this we chose to report all positive cultures -including those with 'scanty' growth that may have artificially inflated our figures compared to other studies. Our small numbers do not allow us to comment on the differences between ICU versus operating theatre insertion. It is interesting to note that in the six patients with culture-positive sleeve fluid, in four patients (66%) another site was culture-positive and with the same organism -and in three of these four the exit site was culture-positive. Thus, in 50% of the patients with culture-positive PAC sleeve fluid, the skin exit site was also positive and yielded the identical organism as the sleeve fluid. This finding is difficult to interpret in light of the small sample size, short duration of catheterisation and the absence of catheter-related bloodstream infection or local site infection. However, it is consistent with the reported high positive predictive value of 'surveillance' surface cultures to identify organisms that may be responsible for bloodstream infection 19 .
Our study has several limitations. First, over 90% of our patients were on at least one antibiotic at the time of catheter removal. This reflects current surgical practice, and antibiotic use in patients with predominantly medical conditions may have been slightly lower. All patients with positive sleeve cultures were on antibiotic therapy. Thus, if antibiotic use protects the PAC sleeve from becoming colonised, our figures may underestimate the prevalence of positive sleeve cultures in a mixed but low-risk population of critical care patients 21 .
Second, our culture techniques and reporting methods may have increased our yield of positive cultures compared to other studies. However, we believe it is more precise and meaningful to report the surface cultures semi-quantitatively, which is the routine diagnostic laboratory protocol at our institution, rather than use the terms "contamination" and "colonisation" which may lead to confusion. This has been adopted as the standard laboratory operating and reporting procedure in our institution.
Third, we used the Maki roll-plate technique for all catheter-tip cultures. Although this is the gold standard, in one meta-analysis 22 it was estimated to have both a sensitivity and specificity of only 85%, and newer methods (e.g. sonification and endoluminal sampling) may be more precise. Importantly, the Maki technique frequently fails to detect intraluminal colonisation 22 . In a large prospective study using molecular subtyping, Mermel et al showed that about 75% of PAC-related infections occurred via the extraluminal route and about 25% via endoluminal contamination from the hub of the infusate 23 .
Fourth, there is no reference standard for the culture of the fluid that we obtained from inside the protective sleeve. However, based on the assumption that any organism in a sealed and 'sterile' space from which a device is advanced into the bloodstream can be potentially pathogenic, we considered any CFU per ml of sleeve fluid a positive culture.
Finally, the majority of our patients underwent elective, 'clean' cardiac surgery. In critically ill patients admitted for medical conditions, the results may have been different. Most studies of this topic in the literature only examined catheters at a time of increased risk (after four days of insertion). We would thus predict a higher rate than our current figures show, if the catheters had remained in place longer. Hence, we believe that our results are a conservative but valid estimate. In order to answer the original question regarding the sterility of the PAC sleeve, our findings of 6% colonised sleeves after approximately one day (1.25 exactly) are clearly of concern.
CONCLUSION In this cohort of 102 patients with a short duration of pulmonary artery catheterisation, six patients had potentially infective cultures of PAC sleeve fluid, and in half of these the cultured organism was identified on a swab of the exit site. We were unable to identify any predictive factors on the basis of univariate analysis. The exact period of sterility following insertion remains to be determined. While this must be considered preliminary data, it would seem unwise to permit advancement of the pulmonary artery catheter within this sleeve except within a very limited period following insertion. Until further work has been done, we consider the sleeve not to be a sterile barrier and our unit policy will remain that no manipulation should occur beyond four hours after insertion.
